Immunohistopathologic findings in herpes simplex virus chorioretinitis in the von Szily model.

Invest Ophthalmol Vis Sci

Hilles Immunology Laboratory, Massachusetts Eye and Ear Infirmary, Boston 02114.

Published: January 1992

After anterior chamber inoculation of herpes simplex virus type 1 (HSV-1), some mice have a characteristic pattern of ocular disease, including ipsilateral anterior uveitis, relative sparing of the ipsilateral retina, and necrotizing contralateral chorioretinitis. It was reported previously that susceptibility to the contralateral chorioretinitis is associated with the Igh-1 locus; congenic mice differing at this locus have different rates of contralateral disease. The immunohistopathologic findings of this model in Igh-1 disparate congenic mice are reported after examining immune cell populations (CD4, CD8, Thy 1.2, Ia, Mac, and immunoglobulin G cells) in both ipsilateral and contralateral eyes and the recruitment kinetics of these cell types in various ocular tissues. In both HSV-susceptible BALB/c and HSV-resistant C.B-17 mice, the ipsilateral eye undergoes early cellular infiltration, and the contralateral retina is devoid of cells until day 10 postinoculation. In BALB/c mice, a late dramatic rise develops in Mac and Ia cells in the ipsilateral and contralateral choroid (P less than 0.005) compared with C.B-17 mice. The C.B-17 mice have an earlier, mild cellular infiltration of the uveal tract in the ipsilateral eye, abrogation of the late Mac and Ia cellular recruitment in the ipsilateral choroid, and an absent contralateral response. These strain-specific immunohistopathologic differences help to explain Igh-1-linked HSV retinitis patterns in this model.

Download full-text PDF

Source

Publication Analysis

Top Keywords

cb-17 mice
12
immunohistopathologic findings
8
herpes simplex
8
simplex virus
8
contralateral chorioretinitis
8
congenic mice
8
cells ipsilateral
8
ipsilateral contralateral
8
ipsilateral eye
8
cellular infiltration
8

Similar Publications

This study evaluates the efficacy of [I]I-ERIC1 in targeting and inhibiting the growth of SCLC tumors in mice, focusing on tumor accumulation and regression and potential side effects. NCAM-positive NCI-H69 SCLC cells were implanted in CB 17 SCID mice, and [I]I-ERIC1 biokinetics were measured in organs and tissues at four post-injection time points (24, 72, 96, and 120 h). The experimental series compared tumor growth, survival, and changes in blood counts among three treatment groups (1, 2, or 3 MBq) and a control group, with treatments initiated either two or five days post implantation.

View Article and Find Full Text PDF
Article Synopsis
  • The veterinary heartworm prevention market is worth billions and is increasingly focusing on alternative drug testing due to drug resistance in dogs and cats.
  • New research shows that specific genetically modified mice (like SCID and RAG2 γc) can be used for heartworm drug screening, reducing reliance on companion animals for testing.
  • The study compares different mouse strains and treatments, revealing promising results with oxfendazole and suggesting that these mice models could aid both academia and industry in developing more effective heartworm treatments.
View Article and Find Full Text PDF
Article Synopsis
  • - This study explored the role of MIAT (a long non-coding RNA) in fibroid tumors and how reducing its levels can affect the tumor environment by increasing levels of the miR-29 family, which is known to regulate gene expression.
  • - Mice with implanted fibroid tissue underwent MIAT knockdown, resulting in a 30% decrease in tumor weight and an increase in miR-29 levels, leading to reduced cell proliferation and expression of genes associated with the cell cycle and collagen production.
  • - The findings suggest that targeting MIAT could be a promising therapeutic approach for treating fibroids, as it helps minimize tumor growth and the accumulation of extracellular matrix, a key feature of these tumors.
View Article and Find Full Text PDF

Shikonin reduces M2 macrophage population in ovarian cancer by repressing exosome production and the exosomal galectin 3-mediated β-catenin activation.

J Ovarian Res

May 2024

Department of Gynaecology, Wuxi Maternity and Child Health Care Hospital, Affiliated Women's Hospital of Jiangnan University, No. 48, Huaishu Lane, Liangxi District, Wuxi, Jiangsu, 214000, P.R. China.

Background: Shikonin (SK), a naphthoquinone with anti-tumor effects, has been found to decrease production of tumor-associated exosomes (exo). This study aims to verify the treatment effect of SK on ovarian cancer (OC) cells, especially on the production of exo and their subsequent effect on macrophage polarization.

Methods: OC cells SKOV3 and A2780 were treated with SK.

View Article and Find Full Text PDF

Lymphatic filariasis and onchocerciasis are two major neglected tropical diseases that are responsible for causing severe disability in 50 million people worldwide, whilst veterinary filariasis (heartworm) is a potentially lethal parasitic infection of companion animals. There is an urgent need for safe, short-course curative (macrofilaricidal) drugs to eliminate these debilitating parasite infections. We investigated combination treatments of the novel anti- azaquinazoline small molecule, AWZ1066S, with benzimidazole drugs (albendazole or oxfendazole) in up to four different rodent filariasis infection models: CB.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!